Patent details

EP3265127 Title: MIFEPRISTONE AND OCTREOTIDE FOR USE IN THE TREATMENT OF CUSHING'S SYNDROME IN A PATIENT HAVING AN ADRENOCORTICOTROPIC HORMONE (ACTH)-SECRETING PANCREATIC NEUROENDOCRINE TUMOR

Basic Information

Publication number:
EP3265127
PCT Application Number:
US2016019646
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167592955
PCT Publication Number:
WO2016140867
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MIFEPRISTONE AND OCTREOTIDE FOR USE IN THE TREATMENT OF CUSHING'S SYNDROME IN A PATIENT HAVING AN ADRENOCORTICOTROPIC HORMONE (ACTH)-SECRETING PANCREATIC NEUROENDOCRINE TUMOR
French Title of Invention:
MIFEPRISTONE ET OCTREOTIDE POUR LE TRAITEMENT DU SYNDROME DE CUSHING CHEZ UN PATIENT AYANT UNE TUMEUR NEUROENDOCRINE PANCRÉATIQUE SÉCRÉTANT L'HORMONE ADRÉNOCORTICOTROPE (ACTH)
German Title of Invention:
MIFEPRISTON UND OCTREOTID ZUR VERWENDUNG BEI DER BEHANDLUNG DES CUSHING-SYNDROMS BEI EINEM PATIENTEN MIT EINEM ADRENOCORTICOTROPEN HORMON (ACTH) SEZERNIERENDEN PANKREATISCHEN NEUROENDOKRINEN TUMOR
SPC Number:

Dates

Filing date:
25/02/2016
Grant date:
21/02/2024
EP Publication Date:
10/01/2018
PCT Publication Date:
09/09/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/02/2024
EP B1 Publication Date:
21/02/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/02/2024
Expiration date:
25/02/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/11/2024
 
 

Name:
Corcept Therapeutics Incorporated
Address:
101 Redwood Shores Parkway, Redwood City, CA 94065, United States (US)

History of Owners

From:
14/02/2024
To:
22/11/2024

Name:
Corcept Therapeutics, Inc.
Address:
149 Commonwealth Drive, Menlo Park CA 94025, United States (US)

Inventor

1

Name:
MORAITIS, Andreas G.
Address:
United States (US)

2

Name:
BELANOFF, Joseph K.
Address:
United States (US)

Priority

Priority Number:
201562127153 P
Priority Date:
02/03/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 45/06; C07D 413/06; A61P 35/00; A61K 38/06; A61K 38/12; A61K 51/08; A61K 31/437; A61K 31/4745; A61K 31/505; A61K 31/513; A61K 31/567; A61P 3/10; A61K 38/08;

Publication

European Patent Bulletin

1

Issue number:
202408
Publication date:
21/02/2024
Description:
Grant (B1)

2

Issue number:
202452
Publication date:
25/12/2024
Description:
Change of owner's name or address

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages